Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q4 FY26
Healthcare Equipment & Supplies
Medical Equipment & Supplies
1,456 Cr
Low Risk
26.1
51.6
1.9
3.0
709.95
431.00
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
Q-Line Biotech Ltd (QLINE) is currently trading at 675.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Q-Line Biotech Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Q-Line Biotech Ltd has traded between a low of ₹431.00 and a high of ₹709.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Q-Line Biotech Ltd has a market capitalization of approximately 1,455.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Q-Line Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 26.12 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,455.80 Cr, Q-Line Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Q-Line Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Q-Line Biotech Ltd is 26.12. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
325.80 | 1,735 Cr | 156.26 | 2.73 | 0.00 | 2.26 | 4.09 | 0.94 | ||
624.05 | 1,456 Cr | 26.12 | 2.98 | 0.00 | 22.63 | 19.42 | 9.98 | ||
198.75 | 1,095 Cr | 38.19 | 4.50 | 0.00 | 13.74 | 14.03 | 9.76 | ||
404.40 | 701 Cr | 62.18 | 4.03 | 0.00 | 5.88 | 7.65 | 5.02 | ||
483.00 | 699 Cr | 38.41 | 4.18 | 0.00 | 13.22 | 14.71 | 6.63 | ||
369.90 | 658 Cr | 22.53 | 3.24 | 0.00 | 14.31 | 18.03 | 8.19 | ||
148.35 | 652 Cr | 13.39 | 1.55 | 0.41 | 9.14 | 10.71 | 7.45 | ||
| Median: 7 Co. | — | 369.90 | 701 Cr | 38.19 | 3.24 | 0.00 | 13.22 | 14.03 | 7.45 |
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
15
Bullish
24
Bearish
0
Neutral
12
Bullish
20
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
3
Bullish
4
Bearish
0
Neutral
12
Bullish
20
Bearish
0
Neutral
12
Bullish
20
Bearish
0
Neutral
12
Bullish
20
AGM/EGM Notice
Q-Line Biotech Ltd published a newspaper notice for its 16th AGM to be held on 2026-09-30 at 16:00 IST in physical mode at The Centrum Hotel, Lucknow; e-voting instructions and annual report availability provided.
Regulatory/Compliance Filing
Q-Line Biotech Ltd corrected a typographical error in intimations dated 07-09-2026: the subject incorrectly stated '37th AGM' instead of the correct '16th AGM'. Notice and Annual Report remain unchanged; error confined to subject line.
AGM/EGM Notice
Q-Line Biotech Ltd notified shareholders of its 16th Annual General Meeting on September 30, 2026 at 04:00 PM (physical). Remote e-voting: Sept 27 09:00 IST to Sept 29 17:00 IST; cut-off date Sept 23, 2026.
